Lung Cancer Awareness Month 2021 — 2 FUNdraisers for LC Research!


In honor of Lung Cancer Awareness Month (LCAM), Lisa Goldman, one of the co-founders of The ROS1ders, is holding two FUNdraising events to raise money for ROS1+ cancer research. Lisa is a Certified Zentangle Teacher (“CZT”) and both events will be Zentangle classes (you can learn more about the Zentangle Method and Lisa’s classes here). … Continue reading Lung Cancer Awareness Month 2021 — 2 FUNdraisers for LC Research!

The ROS1ders host “Searching for a Cure–The ROS1 Cancer Model Project” webinar November 9, 2021


Ever wonder what The ROS1ders do to accelerate ROS1+ cancer research?  Join us for a Zoom webinar titled, “Searching for a Cure: The ROS1 Cancer Model Project” on Tuesday November 9 at 2 pm Pacific Standard Time. Moderator Janet Freeman-Daily of The ROS1ders will be joined by researcher Anh Le of the University of Colorado … Continue reading The ROS1ders host “Searching for a Cure–The ROS1 Cancer Model Project” webinar November 9, 2021

AEACaP and Lung Cancer Europe (LuCE) host “ROS-1 Lung Cancer Patients” webinar on 26-Mar-2021


The Spanish Association of Lung Cancer Patients (AEACaP) and Lung Cancer Europe (LuCE) will be hosting the webinar “ROS-1 Lung Cancer Patients” on Friday, March 26th, 2021 at 18.00 Central European Time (10 am Pacific Time). The event will provide information about the ROS1 biomarker and treatment in lung cancer, as well as research and … Continue reading AEACaP and Lung Cancer Europe (LuCE) host “ROS-1 Lung Cancer Patients” webinar on 26-Mar-2021

The ROS1ders publishes report to move ROS1+ cancer research forward


Today The ROS1ders published a white paper titled, “Sustaining and Accelerating Research for ROS1 Cancer.” The document summarizes key themes and subsequent discussions from two ROS1ders Research Roundtable virtual meetings, which brought together members of The ROS1ders with leading ROS1 clinicians and researchers. The report also offers a “Call to Action” to help move ROS1 … Continue reading The ROS1ders publishes report to move ROS1+ cancer research forward

Last Chance to register for @IASLC #TTLC21


LAST CHANCE to register for the IASLC 2020 Targeted Therapies in Lung Cancer Meeting (to be held THIS WEEK February 17-20). The program is a series of 5-minute presentations on lab research and clinical trials for targeted therapies. The session on ALK & ROS1 inhibitors happens on Thursday February 18 at 14:40 Eastern Time.   This … Continue reading Last Chance to register for @IASLC #TTLC21

Pulmonary hypertension in ROS1+ patients on TKIs


Two independent studies found ROS1+ lung cancer patients are more likely to develop blood clots than patients who have other lung cancers. Pulmonary embolisms are not uncommon in the ROS1ders, and these types of blood clots can eventually result in pulmonary hypertension (because it increases pressure on the heart). The appearance of a new blood … Continue reading Pulmonary hypertension in ROS1+ patients on TKIs